Staar Surgical Co (NAS:STAA)
$ 25.12 +0.91 (+3.76%) Market Cap: 1.25 Bil Enterprise Value: 1.12 Bil PE Ratio: 0 PB Ratio: 3.55 GF Score: 83/100

Q3 2024 STAAR Surgical Co Earnings Call Transcript

Oct 30, 2024 / 08:30PM GMT
Release Date Price: $29.49 (-2.64%)

Key Points

Positve
  • Staar Surgical Co (STAA) achieved net sales of $88.6 million, reflecting double-digit sales growth despite a challenging macroeconomic environment.
  • The company celebrated the grand opening of the new EVO ICL Experience Center, which is designed to enhance training and education for surgeons and healthcare staff.
  • Staar Surgical Co (STAA) reported strong regional performance, with 14% sales growth in the Americas and 12% in EMEA, driven by the Middle East and European distributor markets.
  • The company continues to gain market share in key regions, including a 16% sales growth in the US and 15% in Japan.
  • Staar Surgical Co (STAA) maintains a strong balance sheet with $236 million in cash, cash equivalents, and investments, providing flexibility for capital allocation decisions.
Negative
  • The macroeconomic environment in China softened, impacting sales momentum in the second half of the quarter.
  • Gross profit margin decreased to 77.3% from 79.2% due to reduced unit production and less absorption of fixed overhead.
  • Operating expenses increased by 10% year-over-year, driven by higher facilities costs and compensation-related expenses.
  • The US refractive market was more challenging than anticipated, with a 18% year-over-year decline.
  • The company faces potential competitive pressure in China from new entrants in the implantable lens category.
Operator

Greetings and welcome to the Star Surgical third quarter, 2024 earnings webcast. As a reminder, this event is being recorded today Wednesday, October 30th 2024.

During today's presentation, all parties will be in a listen-only mode following the presentation, the call will be open for questions.

If you have a question, please press the star key, followed by one on your touchtone phone.

If you are using speaker equipment today, please lift the handset before making your selection.

I would now like to introduce your host, Brian Moore, Vice President of Investor Relations with Star Surgical. Please go ahead.

Brian Moore
STAAR Surgical Co - Investor Relation, Vice President, Media Relations, Corporate Development

Thank you, operator. Good afternoon, everyone and thank you for joining us to discuss the company's financial results for the third quarter ended September 27th 2024.

Today's speakers are Tom Frenzy chair of the board President and CEO and Patrick Williams Chief Financial Officer.

The press

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot